The largest database of trusted experimental protocols

13 protocols using stemmacs media

1

Autofluorescence Microspectroscopy of hMSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
A previously reported autofluorescence microspectroscopy protocol for fibroblasts25 (link) was adopted for hMSCs based on their similar adherent nature. Selected passages of hMSCs were seeded at a concentration of at least 3.0 × 10 4 cells/ml on glass coverslips (Schott) within square silicone wells fabricated from medical grade silicone (Wacker Chemie AG). These coverslips with cells in 1 ml of StemMACS media (Miltenyi Biotec) were then incubated in a CO 2 incubator for 24 h before autofluorescence microspectroscopy. Prior to measurements, the culture media was extracted and the remaining contents in the wells were washed twice with 1 ml of PBS. After washing, any excess PBS was remove and 100 μl of imaging solution (Thermo Fisher Scientific) was added. Five phase contrast images were obtained per coverslip at random locations through a 4 × objective. Autofluorescence images and spectra were then taken through a 60 × oil-immersion super apochromat objective (Olympus). At least 100 cells per early and senescent passage per donor were involved in each autofluorescence run. Autofluorescence output of at least 10 cells were recorded with measurements made at different locations within the silicon well (experimental repeats n = 10). This was followed by five background spectral measurements of a 100 μl volume of imaging solution placed on a clean region of the same coverslip.
+ Open protocol
+ Expand
2

Fibrotic Tissue Collection and Analysis for Bone Fracture Repair

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fibrotic NU tissue was collected directly from the NU site. At the time of surgery, following exposure of the fracture site, the fibrotic tissue lying directly between the fractured bone fragments was excised and collected for study.
Samples for the IP were collected at a mean time of 7.6 weeks (range 6–9) from the first stage of the technique (insertion of cement spacer). Approximately 1 cm of membrane tissue was harvested from the center of the bone defect area. Tissue was either digested by incubation in collagenase solution to generate a single cell suspension for culture initiation or flow cytometry analysis, or processed for histology [38 (link)]. A subset of samples tissue was bisected for both enzymatic digestion and processing for histology. BM aspirates were seeded directly in culture in StemMACS media (Miltenyi Biotec, Bisley, Surrey, UK) with penicillin and streptomycin (Thermo Fisher Scientific, Paisley, UK) to generate BM MSC cultures, as previously described [38 (link)].
+ Open protocol
+ Expand
3

Tri-Culture Microenvironment Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human fibroblasts (HS-27), adipose derived stem cells (ASC), and TNBC cells (MDA-MB-231) were all purchased as cell lines from Lonza. Cultures of individual cell types were carried out under normal conditions (37 °C, 5% CO2). HS-27 and MDA-MB-231 were cultured in Dulbecco’s modified Eagle’s medium, 10% fetal bovine serum, 1% PenStrep (Gibco). ASCs were cultured in StemMACS media (Miltenyi Biotech), with 1% PenStrep. Co-cultures were arranged per Figure 1A. Group (i) (cancer juxtacrine group) featured all three cell types combined, in equal number (9.6 cm2 = 50,000 total cells). Group (ii) (cancer paracrine group) had 25,000 HS-27 and 25,000 ASCs per 9.6 cm2 and an overlying boyden chamber containing 20,000 MDA-MB-231. Group (iii) (healthy group) had 25,000 HS-27 and 25,000 ASCs per 9.6 cm2.
+ Open protocol
+ Expand
4

Quantifying Sca1+ Cell Uptake of PKH67+ EVs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Four hours following the incubation of Sca1+ cells with PKH67+ EVs (109 particles per 4 × 105 cells) in the StemMACS media (Miltenyi Biotec), cells were stained with cell surface markers (SLAM). Cells were fixed and permeabilized with BD Cytofix/Cytoperm Plus Fixation/Permeabilization Kit and Permeabilization Buffer Plus (BD Biosciences). We used the p-Smad2 (S465/467) antibody (#18338, Cell Signaling Technology) and the secondary anti-Rabbit-AF568 antibody (Thermo Fisher Scientific). Then, SLAM cells were purified by FACS and applied on a glass slide (Superfrost plus, Thermo Fisher Scientific) for up to 10 min and fixed with ProLong Gold Antifade reagent containing DAPI (P36931, Thermo Fisher Scientific). Fluorescent images were acquired with an Axio Imager M2 (Zeiss). Fluorescent optical sections of cells were obtained under magnification ×63 using an Axio Imager M2 (Zeiss) coupled with an Apotome.2 (Zeiss). Fluorescent images were processed for study (Fiji, NIH software).
+ Open protocol
+ Expand
5

Generating Bioluminescent Patient-Derived Xenograft Models

Check if the same lab product or an alternative is used in the 5 most similar protocols
We created PDX models that developed stable bioluminescence by infecting T-ALL and B-ALL cells with a lentivirus expressing both GFP and luciferase. Then, we transplanted these cells into mice that were used later to perform bioluminescence imaging. The lentivirus was produced in HEK293 cells after transduction with Lipofectamin 2000 (Thermo Fisher Scientific) of the pCCLc-MNDU3-Luciferase-PGK-EGFP-WPRE vector (Addgene, #89608), as well as PAX2 (Addgene, #12260) and pCMV-VSV-G (Addgene, #8454) plasmids. After two days, viral supernatants were recovered, and six-well plates were incubated 4 h with retronectin (Takara, Ozyme). Viral supernatants were then spinoculated for 30 min at 4,000 g. Cells were cultured on these plates for three days in StemMACS media (Miltenyi Biotech). Lentiviral transduced cells (GFP+) were sorted on a FACSAriaIII cell sorter (BD Biosciences) and transplanted in NSG mice to generate bioluminescent PDX models. Animals were injected with potassium salt of D-luciferin (150 mg/kg body weight). Following isoflurane-induced anesthesia, animals were imaged 20 min after D-luciferin injection using an IVIS Lumina III system coupled to Living Image acquisition and analysis software version 4.0 (Perkin Elmer).
+ Open protocol
+ Expand
6

Isolation and Culture of MSCs from Iliac Crest and Femoral Periosteum

Check if the same lab product or an alternative is used in the 5 most similar protocols
MSCs, isolated from iliac crest BMA and femoral periosteum (Male, 17) as previously described (31), were grown in tissue culture until passage 3 (P3) was reached and re-suspended as 5 × 103 or 5 × 104 cells per mL in StemMACS media (Miltenyi Biotec). In triplicate, 200 μL of cell suspension (either 103 or 104 cells, of either periosteum or BM MSCs) was pipetted onto PCL3%-E (4 cm2), sterilised under UV light for 1 h in a class II fume hood, and left to attach for 4 h, at 37 °C, 5% CO2, and grown in vitro. At timepoints over 4 weeks, samples were taken, washed in PBS, fixed in 3.75% (vol. %) formaldehyde overnight, and imaged using confocal microscopy (20× magnification, Leica Confocal Microscope, DM6 CS), staining protocols in supplementary material.
+ Open protocol
+ Expand
7

Bioluminescent PDX model of B-ALL

Check if the same lab product or an alternative is used in the 5 most similar protocols
We created PDX models that developed stable bioluminescence by infecting B-ALL cells #2 with a lentivirus expressing both GFP and luciferase [67 (link)]. Then, we transplanted these cells into mice that were used later for bioluminescence imaging. The lentivirus was produced in HEK293 cells after transduction with Lipofectamin 2000 (Thermo Fisher Scientific) of the pCCLc-MNDU3-Luciferase-PGK-EGFP-WPRE vector (Addgene, #89608), as well as PAX2 (Addgene, #12260) and pCMV-VSV-G (Addgene, #8454) plasmids. After 2 days, viral supernatants were recovered, and 6-well plates were incubated for 4 h with retronectin (Takara, Ozyme). Viral supernatants were then spinoculated for 30 min at 4000×g. Cells were cultured on these plates for three days in StemMACS media (Miltenyi Biotech). Lentiviral transduced cells (GFP+) were sorted on a FACSAriaIII cell sorter (BD Biosciences) and transplanted in NSG mice to generate bioluminescent PDX. Following isoflurane-induced anesthesia, animals were imaged 15 min after d-luciferin (Merck) injection, at 150 mg/kg body weight, using an IVIS Lumina III system coupled with Living Image acquisition and analysis software version 4.0 (Perkin Elmer).
+ Open protocol
+ Expand
8

Selective Targeting of CML LSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
To check the selectivity of our carrier CD26+ and CD26− cells were treated with Rhodamine-conjugated immunoliposomes (IL-Rho). 1 × 104 cells were plated in 96 wells plate and after the addition of immunoliposome (40 µL/mL), the selectivity was measured by flow cytometry analysis after 4 h of treatment. Meanwhile, cells were labeled with Carboxyfluorescein succinimidyl ester (CFSE) (Molecular Probes), were treated with IL-Rho and were analyzed by confocal microscopy. To check the selectivity of this system on primary cells, patient samples were sorted with FACSAria Ⅲ cell sorter (BD Biosciences, San Jose, CA, USA) based on CD45dim/CD34+/CD38−/CD26− for HSCs and CD45dim/CD34+/CD38−/CD26+ for CML LSCs. After the sorting, cells were cultured in StemMACS media (Miltenyi Biotec, Bergisch Gladbach, Germany) supplemented with the abovementioned growth factors and were treated with the designed IL-Rho for 4 h. The selectivity assay was carried out using flow cytometry and confocal analysis.
+ Open protocol
+ Expand
9

Isolation and Culture of CML Patient-Derived Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For this study, bone marrow (BM) and peripheral blood (PB) of newly diagnosed and TKI-resistant CML patients were collected as part of the Italian national study GIMEMA CML1415—Sustrenim, approved by the Ethical committee of the Coordinating Center on 11 May 2016. All samples were de-identified. Also BM samples of three healthy donors were collected after informed consent. Mononuclear cells (MNCs) were isolated from both BM and PB using Ficoll-Hypaque (Sigma Aldrich, Milan, Italy). MNCs were cultured in stemMACS media (Miltenyi Biotec, Bergisch Gladbach, Germany) supplemented with FLT-3L (100 ng/mL), SCF (100 ng/mL), IL-3 (20 ng/mL), and TPO (20 ng/mL). For all experiments that contain primary cells, fresh samples were used.
+ Open protocol
+ Expand
10

Evaluating CD34+ HSC Therapy for B-ALL

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mononuclear cells were isolated from two cord blood samples following Pancoll (Pan Biotech) density gradient centrifugation. CD34+ cells were recovered with magnetic beads (130-046-702, Miltenyi Biotec) and divided into 4 wells in 1 mL of StemMACS media (Miltenyi Biotec), supplemented with PSA (Pan Biotech), human stem cell factor (SCF, 25 ng/mL, 130-093-991, Miltenyi Biotec), human Interleukin 3 (IL3, 10 ng/mL, 130-093-908, Miltenyi Biotec), and human Interleukin 6 (IL6, 10 ng/mL, 130-095-365, Miltenyi Biotec). CD34+ cells were deliberately contaminated with 1% of GFP+ B-ALL cells (#1 or #2). The mix of CD34+ and GFP+ B-ALL cells was treated with 2000 particles/cell. Eighteen hours later, cells were washed with PBS 1×, then 1.5 × 105 cells in physiological saline solution were transplanted in NSG mice and irradiated 24 h before the transplantation at a sublethal dose of 1.5 Gray (BioMEP, Bretenière, France). After 5 weeks, the development of B-ALL was monitored by GFP expression in BM. CD34+ HSC reconstitutions were assessed by flow cytometry in PB and BM. We also determined the disappearance of GFP+ cells in vitro by flow cytometry 48 h after the treatment.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!